Drug interactions

Current Opinion in Anaesthesiology

Volumn 14, Issue 4, 2001, Pages 411-416

  Olkkola, Klaus T ^a   Ahonen, Jouni ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; CAFFEINE; CLOMIPRAMINE; CODEINE; DIAZEPAM; DICLOFENAC; ENZYME INDUCING AGENT; ENZYME INHIBITOR; ETHYLMORPHINE; HALOTHANE; IBUPROFEN; IMIPRAMINE; ISOFLURANE; LIDOCAINE; MIDAZOLAM; MOCLOBEMIDE; OMEPRAZOLE; OXYCODONE; PARACETAMOL; PHENYTOIN; PROPRANOLOL; ROPIVACAINE; THEOPHYLLINE; TRAMADOL; TRIAZOLAM; UNINDEXED DRUG; WARFARIN;

DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG STABILITY; DRUG TRANSFORMATION; PRIORITY JOURNAL; REVIEW;

EID: 0034935814     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200108000-00006     Document Type: Review

References (25)

1. How many deaths occur annually from adverse drug reactions in the United States?
2. Polypharmacy in a general surgical unit and consequences of drug withdrawal
3. Drug interactions and multiple drug administration
4. What is synergy?
5. Response surface model for anesthetic drug interactions
6. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition
7. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole
8. Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole
9. Pharmacokinetic drug interactions in anesthetic practice
10. Age-related changes in protein binding of drugs: Implications for therapy
11. Ritonavir's role in reducing fentanyl clearance and prolonging its half-life
12. The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine
13. Effect of buprenorphine on CYP3A activity in rat and human liver microsomes
14. Lack of interaction of buprenorphine with flunitrazepam metabolism
15. The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro
16. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine
17. Herb-drug interactions
18. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice
19. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model
20. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects
21. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice
22. P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
23. Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein